$499 per month
Blood work included
MD and NP Supervised

Semaglutide is a medication that has also been approved for use in the treatment of obesity. It is available under the brand name Wegovy for this purpose.

Semaglutide has been shown in clinical trials to promote weight loss by reducing appetite and food intake. It works by activating receptors in the brain that control hunger and satiety, leading to a feeling of fullness and reducing the desire to eat.

In clinical trials, people who took semaglutide for weight loss experienced significant reductions in body weight and body mass index (BMI) compared to those who received a placebo. The medication is administered once a week as an injection and is used in conjunction with a reduced-calorie diet and increased physical activity.

It is important to note that semaglutide is not a substitute for healthy lifestyle changes and should only be used under the guidance of a healthcare provider.

Semaglutide is a prescription medication that has been approved by the FDA for the treatment of obesity, and it has been shown to be safe and effective in clinical trials.

However, like any medication, Semaglutide may not be appropriate for everyone. Before starting Semaglutide, it is important to talk to our NP about your medical history, current medications, and any other factors that may affect your safety while taking this medication.

In particular, Semaglutide may not be recommended for people who have a history of pancreatitis or other digestive issues, thyroid cancer, or a personal or family history of medullary thyroid cancer. Additionally, Semaglutide may interact with other medications, so it is important to inform your healthcare provider of all medications, vitamins, and supplements you are currently taking.

At our Rêvée, we are committed to providing safe and effective weight loss solutions tailored to your individual needs and goals.

The amount of time it takes to see results from Semaglutide may vary depending on a number of factors, including individual response to the medication, dosage, and adherence to diet and exercise recommendations.

In clinical trials for Semaglutide, participants who took the medication for weight loss typically saw significant results within 16 to 20 weeks. After 68 weeks of treatment, participants had an average weight loss of around 15% of their initial body weight.

However, it is important to remember that weight loss is a gradual process, and results may vary from person to person. It is also important to use Semaglutide in combination with a healthy diet and regular exercise regimen to achieve the best possible results.

Semaglutide at Rêvée in Richmond, VA

Call us or book online to get started!